Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Comparative bio-availability of four formulations of furosemide.

Meyer BH, Müller FO, Swart KJ, Luus HG, Werkman IM.

S Afr Med J. 1985 Oct 26;68(9):645-7.

PMID:
3904040
2.

Penbutolol and furosemide in a fixed-dose combination-bio-equivalence of two formulations.

Meyer BH, Müller FO, Hundt HK, Grigoleit HG, Hajdu P, Heptner W.

S Afr Med J. 1981 Jun 13;59(25):891-3.

PMID:
7015536
3.

Implications of intraindividual variability in bioavailability studies of furosemide.

Grahnén A, Hammarlund M, Lundqvist T.

Eur J Clin Pharmacol. 1984;27(5):595-602.

PMID:
6519165
4.

A bioequivalence study of two products of furosemide tablets.

Awad R, Arafat T, Saket M, Saleh M, Gharaibeh M, Zmeili S, Sallam E, Shubair M, Qobrosi S.

Int J Clin Pharmacol Ther Toxicol. 1992 Jan;30(1):18-23.

PMID:
1551740
5.

Bioequivalence evaluation of two brands of furosemide 40 mg tablets (Salurin and Lasix) in healthy human volunteers.

Najib N, Idkaidek N, Beshtawi M, Bader M, Admour I, Alam SM, Zaman Q, Dham R.

Biopharm Drug Dispos. 2003 Sep;24(6):245-9.

PMID:
12973821
6.

Comparative bioavailability of two furosemide formulations in humans.

Martin BK, Uihlein M, Ings RM, Stevens LA, McEwen J.

J Pharm Sci. 1984 Apr;73(4):437-41.

PMID:
6726624
7.

Pharmacokinetics and pharmacodynamics of furosemide after direct administration into the stomach or duodenum.

Lee WI, Yoon WH, Shin WG, Song IS, Lee MG.

Biopharm Drug Dispos. 1997 Dec;18(9):753-67.

PMID:
9429740
8.

Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.

Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.

Clin Ther. 2007 Jun;29(6):1146-52.

PMID:
17692728
9.

Bio-availability of three formulations of glibenclamide.

Meyer BH, Müller FO, Luus HG, Eckert HG.

S Afr Med J. 1989 Aug 19;76(4):146-7.

PMID:
2503895
10.

Desorption of furosemide from charcoal in vitro and in man.

Roivas L, Kivistö KT, Neuvonen PJ.

Int J Clin Pharmacol Ther. 1994 Jul;32(7):365-9.

PMID:
7952799
11.

In vivo pharmacokinetic-pharmacodynamic relationship and in vitro equivalence of two oral furosemide tablet formulations.

Cuadrado A, Rodríguez Gascón A, Hernández RM, Castilla AM, de la Maza A, Yánez C, López de Ocáriz A, Solinís MA, Pedraz JL.

Arzneimittelforschung. 2003;53(5):321-9.

PMID:
12854359
12.

Pharmacodynamic and pharmacokinetic study of a slow-release formulation of furosemide in man.

Ebihara A, Tawara K, Oka T.

Arzneimittelforschung. 1983;33(1):163-6.

PMID:
6681970
13.

Pharmacokinetics of an oral frusemide/amiloride combination tablet.

Brooks SG, Christie RB, Roche J, Fairhead AP, Muirhead D, Townsend HA, Shaw HL.

Curr Med Res Opin. 1984;9(2):141-6.

PMID:
6399890
14.

Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study.

Suthisisang C, Payakachat N, Chulavatnatol S, Towanabut S.

J Med Assoc Thai. 1998 Jan;81(1):64-70.

PMID:
9470324
15.

Variable furosemide absorption and poor predictability of response in elderly patients.

Murray MD, Haag KM, Black PK, Hall SD, Brater DC.

Pharmacotherapy. 1997 Jan-Feb;17(1):98-106.

PMID:
9017769
17.

Bioavailability of seven furosemide tablets in man.

Straughn AB, Wood GC, Raghow G, Meyer MC.

Biopharm Drug Dispos. 1986 Mar-Apr;7(2):113-20.

PMID:
3708119
18.

Comparative bio-availability of theophylline whole and halved sustained-release tablets.

Müller FO, Hundt HK, Luus HG, van Dyk M, Groenewoud G, van der Meer MJ, Steinijans VW.

S Afr Med J. 1987 Aug 1;72(3):175-8.

PMID:
3299763
19.

Discrimination between five oral frusemide preparations using renal chloride excretion and frusemide recovery.

Eggers NJ, Kingsford M, Saint Joly CM, Jellett LB, Shirkey RJ.

N Z Med J. 1983 Nov 23;96(744):963-6.

PMID:
6355931
20.

Warfarin bio-availability. A comparison of 4 products.

Müller FO, Steyn JM, Hundt HK, Luus HG.

S Afr Med J. 1988 Dec 3;74(11):566-7.

PMID:
3057655

Supplemental Content

Support Center